Role of Dystroglycan in Prostate Function and Regeneration
Role of Dystroglycan in Prostate Function and Regeneration
批准号:
7482238
负责人:
Michael D Henry
金额:
$18.38万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-08-08 至 2010-04-30
关键词:
AdultAgeAndrogensApoptosisBasal CellBasement membraneBindingBiologyCastrationCell DeathCell LineageCell ProliferationCell Proliferation RegulationCell physiologyCellsControl AnimalDataDevelopmentDiseaseDisruptionDystroglycanECM receptorEnvironmentEpithelialEpithelial Cell ProliferationEpithelial CellsEpitheliumExtracellular MatrixFlow CytometryGoalsHistologyHomeostasisHumanHyperplasiaImmunofluorescence MicroscopyKidneyKnock-outLamininLaminin ReceptorLateralLeadLocalizedLungMaintenanceMalignant NeoplasmsMalignant neoplasm of prostateMammary glandMeasuresMediatingMediator of activation proteinMorphogenesisMusNatural regenerationPhenotypePlayProcessProstateProstatic ductProteinsReportingResearchRoleSkeletal MuscleStem cellsStructureTimeTissuesWithdrawalWorkbasecell growthcell typecohortdystroglycan 1innovationinsightmembrane assemblymutantnovelprogenitorresearch studystemtissue regenerationurologic
中文摘要
描述(由申请人提供):上皮细胞和细胞外基质之间的相互作用对于泌尿系统组织(如前列腺)的正常发育和维持至关重要。我们的长期目标是了解这些相互作用的破坏如何导致前列腺癌。我们一直专注于肌营养不良蛋白聚糖,前列腺上皮细胞上表达的细胞外基质受体,我们牵连在前列腺癌,作为与细胞外基质相互作用的关键介质的作用。在小鼠中使用条件性敲除策略,我们已经确定了肌营养不良蛋白聚糖在调节前列腺细胞增殖中的新作用。在这里,我们提出的研究,以阐明在前列腺上皮细胞增殖的肌营养不良蛋白聚糖的作用,这可能是如何与前列腺的正常功能,包括干/祖细胞介导的更新,这一组织。因此,我们提出了以下具体目标:1)确定肌营养不良蛋白聚糖在小鼠前列腺组织结构和功能中的作用。使用年龄匹配的肌营养不良蛋白聚糖突变小鼠和对照小鼠的队列,我们将分析1-18个月大的小鼠的前列腺细胞组成、增殖和细胞死亡。此外,我们将分析这些小鼠的基底膜结构和分泌功能。2)分析肌营养不良蛋白聚糖在小鼠前列腺再生中的作用。我们将确定是否dystroglycan是雄激素戒断后小鼠前列腺再生所需的,与前列腺干/祖细胞的标志物共表达,并位于前列腺导管近端的细胞上,这是一个假定的干细胞龛。这些研究的成功完成将阐明肌营养不良蛋白聚糖在调节前列腺上皮细胞增殖中的作用,并表明肌营养不良蛋白聚糖在前列腺干/祖细胞功能中的作用。通过首次了解肌营养不良蛋白聚糖在正常前列腺中的作用,我们可以进一步了解肌营养不良蛋白聚糖如何参与前列腺癌的泌尿系统恶性肿瘤。上皮细胞和它们的细胞外基质环境之间的相互作用对于前列腺的适当组织、功能和稳态是至关重要的。在这里,我们将研究肌营养不良蛋白聚糖,细胞外基质受体存在于前列腺上皮细胞,在这些过程中的作用。这项工作是相关的,以了解如何破坏正常的生物学,如果前列腺导致疾病,如前列腺癌。
英文摘要
Description (provided by applicant): Interactions between epithelial cells and the extracellular matrix are critical for the normal development and maintenance of urologic tissues such as the prostate. Our long term objective is to understand how disruption of these interactions contributes to prostate cancer. We have been focused on the role of dystroglycan, an extracellular matrix receptor expressed on prostate epithelial cells which we have implicated in prostate cancer, as a key mediator of interactions with the extracellular matrix. Using a conditional knockout strategy in the mouse, we have identified a novel role for dystroglycan in regulating cell proliferation in the prostate. Here we propose studies to elucidate the role of dystroglycan in prostate epithelial cell proliferation and how this may be related to the normal function of the prostate, including stem/progenitor cell-mediated renewal of this tissue. Accordingly, we have proposed the following specific aims: 1) Define the role of dystroglycan in tissue organization and function of the mouse prostate. Using age-matched cohorts of dystroglycan-mutant and control mice, we will analyze prostate cellular composition, proliferation and cell death in mice 1-18 months old. Additionally, we will analyze the structure of basement membranes and secretory function in these mice. 2) Analyze the role of dystroglycan in regeneration of the mouse prostate. We will determine whether dystroglycan is required for regeneration of the mouse prostate after androgen withdrawal, co-expressed with markers of prostate stem/progenitor cells and located on cells in the proximal prostatic ducts, a putative stem cell niche. The successful completion of these studies will elucidate a role for dystroglycan in regulating cell proliferation of the prostate epithelium and indicate a role for dystroglycan in prostate stem/progenitor cell function. By understanding for the first time the role(s) that dystroglycan plays in the normal prostate, we can further understand how dystroglycan is involved in the urologic malignancy of prostate cancer. Interactions between epithelial cells and their extracellular matrix environment are critical for proper organization, function and homeostasis of the prostate. Here we will investigate the role of dystroglycan, an extracellular matrix receptor present on prostate epithelial cells, in these processes. This work is relevant to understanding how disruption of the normal biology if the prostate lead to diseases such as prostate cancer.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Dystroglycan is not required for maintenance of the luminal epithelial basement membrane or cell polarity in the mouse prostate.
维持小鼠前列腺管腔上皮基底膜或细胞极性不需要肌营养不良聚糖。
DOI:
10.1002/pros.21110
发表时间:
2010
期刊:
The Prostate
影响因子:
--
作者:
[Esser,AlisonK, Cohen,MichaelB, Henry,MichaelD]
通讯作者:
Henry,MichaelD
Influence of hemodynamic shear stress on circulating tumor cells
-
批准号:10442218
-
项目类别:
-
资助金额:$37.37万
-
财政年份:2022
-
负责人:Michael D Henry
-
依托单位:
Influence of hemodynamic shear stress on circulating tumor cells
-
批准号:10573281
-
项目类别:
-
资助金额:$35.91万
-
财政年份:2022
-
负责人:Michael D Henry
-
依托单位:
Improved detection of bladder cancer recurrence using a biophysical biomarker
-
批准号:9988591
-
项目类别:
-
资助金额:$0.2万
-
财政年份:2017
-
负责人:Michael D Henry
-
依托单位:
Effects of fluid shear stress on circulating tumor cells
-
批准号:9111247
-
项目类别:
-
资助金额:$19.84万
-
财政年份:2016
-
负责人:Michael D Henry
-
依托单位:
(PQC2) Resistance to fluid shear stress: a novel biomarker of cancer cells
-
批准号:8589754
-
项目类别:
-
资助金额:$19.71万
-
财政年份:2013
-
负责人:Michael D Henry
-
依托单位:
(PQC2) Resistance to fluid shear stress: a novel biomarker of cancer cells
-
批准号:8721904
-
项目类别:
-
资助金额:$15.93万
-
财政年份:2013
-
负责人:Michael D Henry
-
依托单位:
Effects of pesticides on prostate cancer progression in PTEN mutant mice
-
批准号:7938731
-
项目类别:
-
资助金额:$26.21万
-
财政年份:2009
-
负责人:Michael D Henry
-
依托单位:
Effects of pesticides on prostate cancer progression in PTEN mutant mice
-
批准号:7814051
-
项目类别:
-
资助金额:$31.89万
-
财政年份:2009
-
负责人:Michael D Henry
-
依托单位:
Role of Dystroglycan in Prostate Cancer Progression
-
批准号:7655510
-
项目类别:
-
资助金额:$34.31万
-
财政年份:2008
-
负责人:Michael D Henry
-
依托单位:
Mouse model of obesity and prostate cancer progression.
-
批准号:7742984
-
项目类别:
-
资助金额:$19.68万
-
财政年份:2008
-
负责人:Michael D Henry
-
依托单位:
Role of Dystroglycan in Prostate Cancer Progression
-
批准号:8071515
-
项目类别:
-
资助金额:$29.93万
-
财政年份:2008
-
负责人:Michael D Henry
-
依托单位:
Role of Dystroglycan in Prostate Cancer Progression
-
批准号:8281360
-
项目类别:
-
资助金额:$29.89万
-
财政年份:2008
-
负责人:Michael D Henry
-
依托单位:
Role of Dystroglycan in Prostate Cancer Progression
-
批准号:7524462
-
项目类别:
-
资助金额:$33.39万
-
财政年份:2008
-
负责人:Michael D Henry
-
依托单位:
Mouse model of obesity and prostate cancer progression.
-
批准号:7571031
-
项目类别:
-
资助金额:$16.38万
-
财政年份:2008
-
负责人:Michael D Henry
-
依托单位:
Role of Dystroglycan in Prostate Cancer Progression
-
批准号:7842530
-
项目类别:
-
资助金额:$34.92万
-
财政年份:2008
-
负责人:Michael D Henry
-
依托单位:
Role of Dystroglycan in Prostate Function and Regeneration
-
批准号:7293174
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2007
-
负责人:Michael D Henry
-
依托单位:
Cancer Center Support Grant
-
批准号:10600124
-
项目类别:
-
资助金额:$250.29万
-
财政年份:2000
-
负责人:Michael D Henry
-
依托单位:
DYSTROGLYCAN FUNCTION IN DEVELOPING BASEMENT MEMBRANES
-
批准号:2418486
-
项目类别:
-
资助金额:$2.96万
-
财政年份:1998
-
负责人:Michael D Henry
-
依托单位:
DYSTROGLYCAN FUNCTION IN DEVELOPING BASEMENT MEMBRANES
-
批准号:2796562
-
项目类别:
-
资助金额:$3.15万
-
财政年份:1998
-
负责人:Michael D Henry
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: